×

NOVEL COMPOSITION FOR TREATING METABOLIC SYNDROME

  • US 20080176822A1
  • Filed: 01/16/2008
  • Published: 07/24/2008
  • Est. Priority Date: 01/16/2007
  • Status: Active Grant
First Claim
Patent Images

1. A composition, comprising:

  • a first agent selected from the group consisting of an oxidative phosphorylation inhibitor, an ionophore, and an adenosine 5′

    -monophosphate-activated protein kinase (AMPK) activator;

    a second agent that possesses anti-inflammatory activity; and

    a third agent that possesses or maintains serotonin activity.

View all claims
  • 0 Assignments
Timeline View
Assignment View
    ×
    ×